Equities research analysts expect MedEquities Realty Trust Inc. (NYSE:MRT) to report sales of $15.83 million for the current quarter, Zacks reports. Three analysts have issued estimates for MedEquities Realty Trust’s earnings, with estimates ranging from $15.17 million to $16.52 million. MedEquities Realty Trust posted sales of $13.85 million during the same quarter last year, which suggests a positive year-over-year growth rate of 14.3%. The company is scheduled to issue its next earnings report on Tuesday, November 14th.

On average, analysts expect that MedEquities Realty Trust will report full year sales of $15.83 million for the current fiscal year, with estimates ranging from $59.26 million to $62.82 million. For the next year, analysts forecast that the company will post sales of $77.02 million per share, with estimates ranging from $75.66 million to $78.30 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow MedEquities Realty Trust.

Several equities analysts have recently commented on MRT shares. KeyCorp restated a “buy” rating and set a $13.00 price target on shares of MedEquities Realty Trust in a research note on Friday, August 25th. Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. Finally, Cantor Fitzgerald started coverage on MedEquities Realty Trust in a research note on Thursday, August 31st. They set an “overweight” rating and a $14.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $13.00.

Shares of MedEquities Realty Trust (MRT) opened at 11.54 on Friday. The company has a 50-day moving average of $11.76 and a 200-day moving average of $11.75. MedEquities Realty Trust has a one year low of $10.28 and a one year high of $13.06. The company has a market capitalization of $366.45 million and a PE ratio of 35.08.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 30th. Investors of record on Wednesday, August 16th were given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 7.28%. The ex-dividend date of this dividend was Monday, August 14th. MedEquities Realty Trust’s payout ratio is currently 240.00%.

TRADEMARK VIOLATION WARNING: This news story was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/09/08/brokerages-anticipate-medequities-realty-trust-inc-mrt-will-announce-quarterly-sales-of-15-83-million.html.

Hedge funds have recently modified their holdings of the stock. Teachers Advisors LLC bought a new stake in MedEquities Realty Trust during the fourth quarter valued at about $257,000. Boston Partners boosted its position in MedEquities Realty Trust by 14.1% during the first quarter. Boston Partners now owns 1,202,018 shares of the financial services provider’s stock valued at $13,475,000 after purchasing an additional 148,757 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in MedEquities Realty Trust by 59.0% during the first quarter. Goldman Sachs Group Inc. now owns 2,191,484 shares of the financial services provider’s stock valued at $24,567,000 after purchasing an additional 813,540 shares in the last quarter. Citadel Advisors LLC bought a new stake in MedEquities Realty Trust during the first quarter valued at about $344,000. Finally, Russell Investments Group Ltd. boosted its position in MedEquities Realty Trust by 46.4% during the first quarter. Russell Investments Group Ltd. now owns 449,441 shares of the financial services provider’s stock valued at $5,039,000 after purchasing an additional 142,421 shares in the last quarter. 92.87% of the stock is currently owned by institutional investors.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.